| 摘要 |
The invention relates to compounds of general formula I wherein D, E, F, G, W, Y R, A, R, X, B, Rare as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use alone or in combination with one or more other pharmaceutically active compounds- in therapy, for treating diseases associated with deregulated angiogenese I, such as cancer[I] |
